177 related articles for article (PubMed ID: 35857025)
1. CFTR genotype analysis of Asians in international registries highlights disparities in the diagnosis and treatment of Asian patients with cystic fibrosis.
Vaidyanathan S; Trumbull AM; Bar L; Rao M; Yu Y; Sellers ZM
Genet Med; 2022 Oct; 24(10):2180-2186. PubMed ID: 35857025
[TBL] [Abstract][Full Text] [Related]
2. The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.
Januska MN; Marx L; Walker PA; Berdella MN; Langfelder-Schwind E
J Genet Couns; 2020 Aug; 29(4):607-615. PubMed ID: 32227567
[TBL] [Abstract][Full Text] [Related]
3. Ethnicity impacts the cystic fibrosis diagnosis: A note of caution.
Bosch B; Bilton D; Sosnay P; Raraigh KS; Mak DYF; Ishiguro H; Gulmans V; Thomas M; Cuppens H; Amaral M; De Boeck K
J Cyst Fibros; 2017 Jul; 16(4):488-491. PubMed ID: 28233695
[TBL] [Abstract][Full Text] [Related]
4. Detection of disease-causing CFTR variants in state newborn screening programs.
McGarry ME; Ren CL; Wu R; Farrell PM; McColley SA
Pediatr Pulmonol; 2023 Feb; 58(2):465-474. PubMed ID: 36237137
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and genetics of cystic fibrosis in Asia: In preparation for the next-generation treatments.
Singh M; Rebordosa C; Bernholz J; Sharma N
Respirology; 2015 Nov; 20(8):1172-81. PubMed ID: 26437683
[TBL] [Abstract][Full Text] [Related]
6. The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients: Implications for Molecular Diagnostic Testing.
Schrijver I; Pique L; Graham S; Pearl M; Cherry A; Kharrazi M
J Mol Diagn; 2016 Jan; 18(1):39-50. PubMed ID: 26708955
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants.
Mei-Zahav M; Durie P; Zielenski J; Solomon M; Tullis E; Tsui LC; Corey M
Arch Dis Child; 2005 Jul; 90(7):675-9. PubMed ID: 15970608
[TBL] [Abstract][Full Text] [Related]
8. Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies.
Desai M; Hine C; Whitehouse JL; Brownlee K; Charman SC; Nagakumar P
Respir Med; 2022 Aug; 199():106878. PubMed ID: 35633605
[TBL] [Abstract][Full Text] [Related]
9. Global disparities in cystic fibrosis outcomes prior to CFTR modulators: A CF registries cohort study in South Africa and Canada.
Zampoli M; Sykes J; Verstraete J; Cheng SY; Morrow B; Pepper MS; Stewart C; Zar HJ; Stephenson AL
J Cyst Fibros; 2024 Mar; 23(2):334-340. PubMed ID: 37704465
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients.
Pique L; Graham S; Pearl M; Kharrazi M; Schrijver I
Genet Med; 2017 Jan; 19(1):36-44. PubMed ID: 27148940
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel cystic fibrosis mutation in three patients of South Asian descent.
Semple A; Clark T; Allen NM; Krishnananthan T; Nwokoro C; Girodon E; Porzio M; Herzig M
Clin Respir J; 2020 Jun; 14(6):586-588. PubMed ID: 32043836
[TBL] [Abstract][Full Text] [Related]
12. Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.
Keogh RH; Szczesniak R; Taylor-Robinson D; Bilton D
J Cyst Fibros; 2018 Mar; 17(2):218-227. PubMed ID: 29311001
[TBL] [Abstract][Full Text] [Related]
13. Four case reports of Chinese cystic fibrosis patients and literature review.
Xu J; Yin Y; Zhang L; Zhang J; Yuan S; Zhang H
Pediatr Pulmonol; 2017 Aug; 52(8):1020-1028. PubMed ID: 28608624
[TBL] [Abstract][Full Text] [Related]
14. Diversity of CFTR variants across ancestries characterized using 454,727 UK biobank whole exome sequences.
Ideozu JE; Liu M; Riley-Gillis BM; Paladugu SR; Rahimov F; Krishnan P; Tripathi R; Dorr P; Levy H; Singh A; Waring JF; Vasanthakumar A
Genome Med; 2024 Mar; 16(1):43. PubMed ID: 38515211
[TBL] [Abstract][Full Text] [Related]
15. Detection of F508del mutation in cystic fibrosis transmembrane conductance regulator gene mutation among Malays.
Zilfalil BA; Sarina S; Liza-Sharmini AT; Oldfield NJ; Stenhouse SA
Singapore Med J; 2006 Feb; 47(2):129-33. PubMed ID: 16435054
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of cystic fibrosis in adulthood and eligibility for novel CFTR modulator therapy.
Farley H; Poole S; Chapman S; Flight W
Postgrad Med J; 2022 May; 98(1159):341-345. PubMed ID: 33452147
[TBL] [Abstract][Full Text] [Related]
17. Carrier frequency of CFTR variants in the non-Caucasian populations by genome aggregation database (gnomAD)-based analysis.
Nappo S; Mannucci L; Novelli G; Sangiuolo F; D'Apice MR; Botta A
Ann Hum Genet; 2020 Nov; 84(6):463-468. PubMed ID: 32484936
[TBL] [Abstract][Full Text] [Related]
18. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
19. Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
Hughes EE; Stevens CF; Saavedra-Matiz CA; Tavakoli NP; Krein LM; Parker A; Zhang Z; Maloney B; Vogel B; DeCelie-Germana J; Kier C; Anbar RD; Berdella MN; Comber PG; Dozor AJ; Goetz DM; Guida L; Kattan M; Ting A; Voter KZ; ; van Roey P; Caggana M; Kay DM
Hum Mutat; 2016 Feb; 37(2):201-8. PubMed ID: 26538069
[TBL] [Abstract][Full Text] [Related]
20. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
